Walgreens sells AmerisourceBergen stock for ~$1.9B proceeds
Bruce Bennett/Getty Images News
Pharmacy retailer Walgreens Boots Alliance (NASDAQ:WBA) announced the sale of AmerisourceBergen Corporation's (NYSE:ABC) shares for ~$1.6B current proceeds and potentially additional proceeds of ~$250M.
Per the terms, Walgreens (WBA) will settle prepaid variable share forward transactions at two maturities in Q1 FY26 and Q3 FY26, delivering 10.5M shares of AmerisourceBergen (ABC) common stock.
The additional proceeds result from a concurrent share repurchase that the drug distributor is expected to conduct as part of an agreement with Walgreens (WBA).
While the former transactions have no impact on Walgreens' (WBA) stake in AmerisourceBergen (ABC), the latter is expected to reduce its stake to ~16%.
The Conshohocken, Pennsylvania-based healthcare giant is set to receive additional proceeds of up to $517M from prepaid variable share forward transactions, depending on the share price at the time.
Walgreens (WBA) intends to use the proceeds to pay down its debt and for general corporate purposes.

More on Walgreens 

Walgreens Boots Alliance: The Business Model Is Structurally Broken
Buy Walgreens As Key Targets Approach (Technical Analysis)
Walgreens Boots Alliance Accelerates Healthcare Segment Despite Headwinds
AmerisourceBergen says selling stockholders offering up to 10.5M shares
Walgreens sells AmerisourceBergen shares for ~$694M